Valero Energy Corporation (VLO), Pfizer Inc. (PFE) and American International Group Inc (AIG): Stuyvesant Capital Management’s Largest Stakes Overall
Stuyvesant Capital Management tweaked the composition of its equity portfolio in more than one way during 1Q2015. The fund’s portfolio reforms during the quarter included brand new purchase, increase in holding in certain stocks, decrease in holding in some stocks and total exit of certain equity positions. At the end of the day, the fund’s portfolio was up to $43.9 million from $43.3 million at the end of 4Q2014.
With all the 1Q maneuvers, Stuyvesant Capital Management exited the quarter with its largest interest in terms of industry being in Finance at 30% of total portfolio. The fund’s other large positions are in Energy and Healthcare sectors.
A deeper look into Stuyvesant’s latest regulatory filing discloses that the fund completely sold positions in five stocks during 1Q. The major casualties in the fund’s equity purge were Southern Co (NYSE:SO) and Kimco Realty Corp (NYSE:KIM).
Largest fresh stake
In a positive move, Stuyvesant’s largest fresh position in 1Q was Pfizer Inc. (NYSE:PFE). The fund acquired 84,540 shares in the drug company, a position that was valued at more than $2.9 million at the end of the quarter.
Stuyvesant Capital Management’s portfolio reforms were widespread in 1Q as the fund added stake in seven stocks and reduced holding in five others. Overall, Valero Energy Corporation (NYSE:VLO), Pfizer and American International Group Inc (AIG) featured as the funds best equity picks at the close of 1Q. Here is a closer look at these top-three largest equity positions in the basket of Stuyvesant.
Largest positions overall
Stuyvesant increased its stockholding in Valero Energy Corporation (NYSE:VLO) during 1Q, accumulating a total of 58,861 share in the company at the end of the quarter compared to 57,861 shares in the previous one. The valued of the new position in Valero Energy was $3.7 million at the end of 1Q, higher than $2.9 million at the end of 4Q.
Fresh position in Pfizer
Stuyvesant launched a new position in Pfizer, acquiring 84,540 shares in the stock, with 6.7% of the portfolio portion going to the company.
Stake in AIG unchanged
Stuyvesant Capital Management neither lowered nor increased its holding in insurance giant American International Group Inc (AIG) during 1Q. As such, the fund’s holding in the stock stood at 50,605 shares at the end of 1Q, same as at the end of 4Q. The dollar value in AIG was $2.8 million at the end of the latest quarter.
Latest posts by Neha Gupta (see all)
- Is Facebook Inc (NASDAQ:FB) Winning Or Losing In Virtual Reality Space? - May 27, 2016 07:35 AM PST
- No Growth In Costco Wholesale Corporation (NASDAQ:COST)’s 3Q Comps Explained - May 27, 2016 07:34 AM PST
- How Will International Business Machines Corp. (NYSE:IBM)’s Big Data University Help? - May 27, 2016 07:33 AM PST